We are pleased to announce that Colette Couvillon-McCharen has joined Bimeda as Director, Omni Channel. In this role, Colette will lead our omnichannel strategy, strengthening how we serve custo...
Schaumburg, Illinois— May 12, 2026 — Bimeda is proud to announce the launch of its newly enhanced BOVitalize Plus, now fortified with Aspergillus oryzae (AO) to deliver an even more comprehensive appr...
Now available nationwide. Horse owners are encouraged to contact their veterinarian. Schaumburg, IL — [MAY 5, 2026] — Bimeda® a global leader in animal health solutions, today announced the...
Schaumburg, IL — [APR 6, 2026] — Bimeda®, a global leader in animal health solutions, announced today plans for their U.S. launch of GastrobimTM (omeprazole), the first and only FDA-approved bio...
Schaumburg, Illinois (February 9, 2026) – Bimeda®, the No Suits, Just Boots affordable, no-nonsense animal health solutions manufacturer trusted by producers worldwide, proudly announces the launch of...
Schaumburg, Illinois (January 8, 2026) – Bimeda US, a global leader in animal health solutions, is pleased to announce the launch of a new 250 mL (50‑dose) size of SecureCattle, giving producers a mor...
We are pleased to announce the appointment of Gene Klaft as Territory Manager for the states of Idaho, Washington and Northern Oregon. Gene will be an integral part of US Cattle Sales team. Gene bring...
Oakbrook Terrace, Illinois- March 7, 2022- Bimeda® Animal Health has announced the expansion of its US product portfolio with the re-introduction of OvaCyst® (gonadorelin) and ProstaMate® (dinoprost t...
Bimeda® Inc. announced today the release of KetoMed™ (ketoprofen) (ANADA 200 – 625) for the alleviation of inflammation and pain associated with musculoskeletal disorders in horses. This launch marks ...
Oakbrook Terrace, Illinois (July 19, 2023) – Bimeda Inc. is pleased to announce that SpectoGard (spectinomycin sulfate) Sterile Solution—which received FDA approval in September of 2022—is now availab...
Oakbrook Terrace, Illinois (January 25, 2024) – Bimeda, Inc. has recently launched BOVitalize™ in the US. BOVitalize is an oral vitamin and mineral supplement for beef and dairy cows, bulls and rumina...
Schaumburg, Illinois – Bimeda, Inc. has recently launched Bimasone, the first generic flumethasone for certain diseases that cause inflammation in horses, dogs and cats including rheumatic, aller...
Schaumburg, Illinois (APRIL 14, 2025) – Bimeda is pleased to announce an expansion to its product portfolio with the addition of SecureCattle, an analog of the naturally secreted bovine appeasing pher...
Schaumburg, Illinois (May 19, 2025) – Bimeda is pleased to announce the expansion of its anti-parasitic portfolio with the addition of Doracide. Doracide is bioequivalent to Dectomax® Pour-On (Zoetis®...
Schaumburg, Illinois – Bimeda® US proudly announces the launch of GamrozyneTM, the first and only bioequivalent to Zactran® (Boehringer-Ingelheim®). This milestone expands Bimeda's robust antibi...
We are pleased to announce that Dr. Eric Moore has joined Bimeda as Director of US Technical Services, supporting our Commercial team. Eric brings more than 30 years of leadership and veterinary indus...
Oakbrook Terrace, Illinois (April 1, 2019) – Bimeda® announced today it has available for sale BIMECTIN® PLUS (1% ivermectin and 10% clorsulon) Injection for Cattle. BIMECTIN® PLUS is an injectable pa...
AquaTactics, Bimeda's Washington-based aquaculture division, is excited to announce its entry into the autogenous fish vaccine sector, following USDA approval. Autogenous fish vaccine production...
Bimeda is pleased to announce the launch of a new sustainability-focused website, onebimeda.com. The website details Bimeda's sustainability mission statement and the five Sustainability Pillars which...
Schaumburg, Illinois – Bimeda is excited to announce the expansion of its anti-parasitic portfolio with the introduction of MoxiSolv Injection (moxidectin). MoxiSolv stands out as the only FDA-approve...